The American pharmaceutical company Gilmead Sciences, which promotes the drug Remdesivir in the fight against Covid-19, has found an elegant way to brake the dangerous experiments associated with this obviously useless in the fight against a new coronavirus drug. The company’s image has been saved at least temporarily, and in the dispute about Remdesivir, an ellipsis has been put in place.
The BBC reported on May 13 that “clinical trials of remdesivir have been stopped in the US,” as announced by the US National Institute of Allergy and Infectious Diseases (NIAID), an experiment conducted by the US.
“It is interesting that the tests were not stopped because of their failure – but perhaps quite the opposite. The experiment was terminated, without waiting for the final results, to prevent unnecessary casualties among patients from the control group who took a placebo. Nevertheless, in practice, this decision means that the degree of effectiveness of remdesivir in the fight against coronavirus, which claimed almost 300 thousand lives, will actually have to be checked again, ” the agency said.
Americans are able to “PR” and present defeats as a victory! The chief American immunologist and director of the NIAID Faucci, playing a comedy in front of President Trump, called the course of the experiment encouraging and that the drug allegedly “has a clear significant positive effect, accelerating recovery”, thereby prompting Covid-19 doctors to give Remdesivir to absolutely all patients eliminating their control group (which, as part of the experiment, took a placebo instead of the drug, so that the effect of the drug was something to compare). In this way, the experiment failed and now the effectiveness or inefficiency of the drug has become unprovable.
However, the BBC is forced to admit:
“However, Fauci’s optimism about experimental therapy was initially not shared by everyone. Even intermediate data on drug trials look rather controversial. Forbes magazine, for example, draws attention to the fact that when testing an antiviral drug, it first made sense to look at the viral load of patients. That is, does the concentration of the pathogen in the blood change. However, the authors of the study, announcing the intermediate results, for some reason did not mention this indicator at all.
But the authors of a similar experiment, conducted a little earlier in China, found that remdesivir had no effect on the viral load of Covid-19 patients. It is not surprising that this work comes to the opposite conclusion: the drug is useless to combat the new coronavirus.
There are other reasons why many experts are disappointed with the decision made by the NIAID to prematurely terminate the experiment. Moreover, four times more patients took part in it than in the Chinese study. ”
That is why our agency called the drug of an American company – partner of Lugar Laboratory “useless”, which was followed by angry accusations against the Georgian editorial office of the News Front. In a businesslike tone, but also unjustly criticized, the Georgian-language section of the American government agency Voice of America devoted us. Our publication caused hysteria up to the point that our opponents managed to remove all the pages of the News Front agency from the American Facebook social network.
But now it’s not about that, but about the fact that the Georgian medical administrators associated with the Lugar Laboratory were in a ridiculous position – on the day when the experiment with Remdesivir in the USA stopped, they continued loudly saying “ wonderful “medicine and the need for its experimental implementation in Georgia. They were preparing for the random selection of Georgian patients to participate in the experiment. On May 13, Director of the National Center for Disease Control Professor Amiran Gamkrelidze expressed his readiness to organize experimental treatment of severe patients with Covid-19. And a little earlier, on April 30, the country’s main virologist, Professor T. Tsertsvadze expressed his ardent hope that Georgia would be among the first countries to receive an American miracle cure!
This frivolous behavior of our medical administrators regarding the unfit drug for coronavirus makes it clear that they consider any offers from American pharmaceutical companies to be real gold. The excessive credulity of medical administrators for everything American causes a sense of danger. After all, these people are also involved in the Lugar Laboratory, part of which is classified and there may be conducted any experiments commissioned by American companies. Jokes with biological material are very, very bad.